naringenin has been researched along with Akinetic-Rigid Variant of Huntington Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alam, MI; Parvez, S; Salman, M; Sharma, P; Tabassum, H | 1 |
1 other study(ies) available for naringenin and Akinetic-Rigid Variant of Huntington Disease
| Article | Year |
|---|---|
Naringenin mitigates behavioral alterations and provides neuroprotection against 3-nitropropinoic acid-induced Huntington's disease like symptoms in rats.
Topics: Animals; Antioxidants; Body Weight; Corpus Striatum; Disease Models, Animal; Flavanones; Glial Fibrillary Acidic Protein; Huntington Disease; Monoamine Oxidase; Motor Activity; Neuroprotection; Neuroprotective Agents; Nitro Compounds; Propionates; Rats; Rats, Wistar; Serotonin | 2022 |